methylprednisolone hemisuccinate has been researched along with Deafness, Sudden in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Tao, J; Wang, X; Xu, K; Zhong, Z | 1 |
Forde, CT; Koumpa, FS; Manjaly, JG | 1 |
Acıpayam, H; Alakras, WME; Elbistanlı, MS; Kayhan, FT; Kıral, MN; Koçak, HE | 1 |
Ajduk, J; Gregurić, T; Kalogjera, L; Kelava, I; Košec, A; Ries, M | 1 |
Herr, BD; Marzo, SJ | 1 |
1 trial(s) available for methylprednisolone hemisuccinate and Deafness, Sudden
Article | Year |
---|---|
Are neutrophil/lymphocyte and platelet/lymphocyte ratios related with formation of sudden hearing loss and its prognosis?
Topics: Administration, Oral; Adult; Biomarkers; Blood Platelets; Case-Control Studies; Female; Glucocorticoids; Hearing Loss, Sudden; Humans; Leukocyte Count; Lymphocytes; Male; Methylprednisolone Hemisuccinate; Neutrophils; Prognosis; Retrospective Studies; Treatment Outcome | 2017 |
4 other study(ies) available for methylprednisolone hemisuccinate and Deafness, Sudden
Article | Year |
---|---|
Clinical Efficacy of Retroauricular Injection of Methylprednisolone Sodium Succinate in the Treatment of Sudden Deafness with Type 2 Diabetes.
Topics: Diabetes Mellitus, Type 2; Hearing Loss, Sudden; Humans; Methylprednisolone Hemisuccinate; Prospective Studies; Quality of Life; Treatment Outcome | 2022 |
Sudden irreversible hearing loss post COVID-19.
Topics: Administration, Oral; Betacoronavirus; Coronavirus Infections; COVID-19; Glucocorticoids; Hearing Loss, Sudden; Humans; Injections; Male; Methylprednisolone Hemisuccinate; Middle Aged; Pandemics; Pneumonia, Viral; Prednisolone; SARS-CoV-2 | 2020 |
Recovery From Sudden Sensorineural Hearing Loss May Be Linked to Chronic Stress Levels and Steroid Treatment Resistance.
Topics: Adult; Audiometry, Pure-Tone; Chronic Disease; Cluster Analysis; Cohort Studies; Female; Glucocorticoids; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Longitudinal Studies; Male; Methylprednisolone Hemisuccinate; Middle Aged; Prognosis; Recovery of Function; Retrospective Studies; Stress, Psychological; Treatment Outcome | 2019 |
Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Audiometry, Pure-Tone; Auditory Threshold; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hearing Loss, Sudden; Humans; Male; Methylprednisolone Hemisuccinate; Middle Aged; Middle Ear Ventilation; Perfusion; Retrospective Studies; Round Window, Ear; Treatment Outcome | 2005 |